Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07674797
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Electronic Assessments
- Oncologic
- Palliative Care
- Remote Monitoring
- Telehealth
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Questionnaire and Physical Exam — OTHERPatient will complete questionnaires and physical exams
Study Details
To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs
Key Dates
- Start date
- Nov 22, 2026
- Status verified
- Jun 2026
- Primary completion
- Jun 30, 2032
- Completion
- Jun 30, 2034
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Dose Dense Timely SPC
- Experimental: Enhanced UC
- Experimental: Stadard Timely SPC
Primary Outcome Measure
Self Report Questionnaire [ Time Frame: Through study completion; an average of 1 year ]
Central Contacts
- David Hui, MD713-792-6258
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | David Hui, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2Recruiting · Massachusetts General Hospital · Derby, Connecticut
- Resiniferatoxin to Treat Severe Pain Associated With Advanced CancerPHASE1 · Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone PainPHASE1/PHASE2 · Not Yet Recruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Bethesda, Maryland
- Comparing the Stanford Letter Project Form to Traditional Advance DirectivesRecruiting · Stanford University · Stanford, California